XML 14 R4.htm IDEA: XBRL DOCUMENT v3.22.0.1
Consolidated Statements of Operations And Comprehensive Loss (Unaudited) - USD ($)
$ in Thousands
3 Months Ended 6 Months Ended
Jan. 31, 2022
Jan. 31, 2021
Jan. 31, 2022
Jan. 31, 2021
REVENUE        
Rental – Third Party $ 232 $ 190 $ 428 $ 426
Rental – Related Party 705 527 1,225 1,047
Parking 173 122 363 299
Other – Related Party 120 120 240
Total revenue 1,110 959 2,136 2,012
COSTS AND EXPENSES        
Selling, general and administrative (896) 2,767 11,996 5,359
Research and development 3,335 1,568 5,488 2,083
Depreciation and amortization 381 441 763 878
Provision for loss on receivable pursuant to line of credit 25,000
Provision for losses on related party receivables 10,095
Impairment – Altira 7,000 7,000
Loss from operations (1,710) (10,817) (51,206) (13,308)
Interest expense, net (397) (1) (807) (1)
Gain on sale of building 749
Impairment of investments – Other Pharmaceuticals (724)
Impairment of cost method investment – Rafael Pharmaceuticals (79,141)
Unrealized (loss) gain on investments – Hedge Funds (454) 2,489 (243) 3,433
Loss before income taxes (2,561) (8,329) (131,397) (9,851)
Provision for income taxes (4) (4) (4) (9)
Equity in earnings (loss) of RP Finance 96 (575) 192
Consolidated net loss (2,565) (8,237) (131,976) (9,668)
Net loss attributable to noncontrolling interests (244) (72) (17,631) (57)
Net loss attributable to Rafael Holdings, Inc. (2,321) (8,165) (114,345) (9,611)
OTHER COMPREHENSIVE LOSS        
Consolidated net loss (2,565) (8,237) (131,976) (9,668)
Foreign currency translation adjustment 146 37 155 (1)
Total comprehensive loss (2,419) (8,200) (131,821) (9,669)
Comprehensive loss attributable to noncontrolling interests (330) (62) (17,681) (68)
Total comprehensive loss attributable to Rafael Holdings, Inc. $ (2,089) $ (8,138) $ (114,140) $ (9,601)
Loss per share        
Basic and diluted (in Dollars per share) $ (0.12) $ (0.5) $ (5.91) $ (0.6)
Weighted average number of shares used in calculation of loss per share        
Basic and diluted (in Shares) 19,713,127 16,172,421 19,332,630 15,997,571